Analysis of Prognostic Factors in Patients With Pancreatic Ductal Adenocarcinoma of the Body and Tail
Yuan Jingya,Xiu Dianrong
DOI: https://doi.org/10.3969/j.issn.1009-6604.2023.03.001
2023-01-01
Abstract:Objective To investigate the clinicopathological factors that affect the survival prognosis of pancreatic ductal adenocarcinoma（PDAC） of the body and tail. Methods The clinicopathological data of 112 patients with PDAC of the body and tail undergoing radical distal pancreatectomy from January 2010 to November 2021 were collected retrospectively. The Cox proportional-hazard regression model was used for univariate and multivariate analysis to select the clinicopathological features related to survival prognosis. Results Among the 112 patients, lymphovascular invasion and perineural invasion were identified in 36 and 94 patients, respectively. The median survival time was 19 months, and the 1-, 3-, 5-year survival rates were 67.3%, 27.4% and 14.7%, respectively. In univariate analysis, pathological features such as higher pT stage, TNM stage, lymphnode metastasis and lymphovascular invasion, clinical characteristics such as preoperative CA19-9 level, 1-month postoperative CA19-9 level, surgical method, intraoperative blood loss, combination with vascular resection, and postoperative chemotherapy were related to the survival prognosis of patients with PDAC of the body and tail（all P＜0.05）. In multivariate analysis, lymphovascular invasion（HR=1.938, 95% CI: 1.173-3.201, P=0.010）, higher TNM stage（HR=2.133, 95% CI: 1.045-4.353, P=0.037）, higher postoperative CA19-9 level（HR=2.349, 95% CI: 1.431-3.855, P=0.001）, combination with vascular resection（HR=2.352, 95% CI: 1.229-4.504, P=0.010）, intraoperative blood loss ＞150 ml（HR=2.064, 95% CI: 1.210-3.523, P=0.008）, and without postoperative chemotherapy（HR=2.017, 95% CI: 1.237～3.287, P=0.005） were the independent survival prognostic factors in patients with pancreatic body and tail adenocarcinoma. Conclusion Intraoperative blood loss, combination with vascular resection, postoperative CA19-9 level, postoperative adjuvant chemotherapy, vascular infiltration and TNM stage are independent prognostic factors in patients with pancreatic body and tail adenocarcinoma.